Onconetix (ONCO) Retained Earnings (2023 - 2025)
Historic Retained Earnings for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$136.9 million.
- Onconetix's Retained Earnings fell 5911.41% to -$136.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$136.9 million, marking a year-over-year decrease of 5911.41%. This contributed to the annual value of -$115.7 million for FY2024, which is 10371.79% down from last year.
- Latest data reveals that Onconetix reported Retained Earnings of -$136.9 million as of Q3 2025, which was down 5911.41% from -$128.1 million recorded in Q2 2025.
- Onconetix's Retained Earnings' 5-year high stood at -$22.2 million during Q1 2023, with a 5-year trough of -$136.9 million in Q3 2025.
- Its 3-year average for Retained Earnings is -$80.4 million, with a median of -$82.2 million in 2024.
- In the last 5 years, Onconetix's Retained Earnings plummeted by 20555.88% in 2024 and then crashed by 5581.83% in 2025.
- Over the past 3 years, Onconetix's Retained Earnings (Quarter) stood at -$56.8 million in 2023, then tumbled by 103.72% to -$115.7 million in 2024, then decreased by 18.34% to -$136.9 million in 2025.
- Its last three reported values are -$136.9 million in Q3 2025, -$128.1 million for Q2 2025, and -$125.4 million during Q1 2025.